2-amino-6-trifluoromethoxy benzothiazole (PK 26124), a proposed antagonist of excitatory amino acid neurotransmission, does not produce phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys

W. Koek, J. H. Woods

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

PK 26124, a proposed excitatory amino acid antagonist, was compared to mephenesin and phencyclldine (PCP).In pigeons, PK 26124 and mephenesin produced loss of righting that was to some extent associated with eye closure and muscle relaxation, whereas PCP produced catalepsy, i.e., loss of righting without eye closure and without muscle relaxation. PK 26124, but not nephenesin, produced PCP-like discriminative stimulus effects in some but not all pigeons.In rats, PK 26124 and mephenesin produced loss of righting but did not induce locomotion, sniffing, swaying and falling, unlike PCP.In rhesus monkeys, PK 26124 did not Induce ketamine-like discriminative stimulus effects.While PK 26124 may share some biochemical properties with excitatory amino acid antagonists these do not lead to behavioral effects similar to PCP.

Original languageEnglish (US)
Pages (from-to)771-775
Number of pages5
JournalNeuropharmacology
Volume27
Issue number7
DOIs
StatePublished - Jul 1988
Externally publishedYes

Keywords

  • 2-amino-6-trlfluoromethoxy benzothiazole
  • PK 26124
  • catalepsy
  • drug discrimination
  • mephenesin
  • midazolam
  • phencyclldine
  • pigeons
  • rats
  • rhesus monkeys

ASJC Scopus subject areas

  • Pharmacology
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of '2-amino-6-trifluoromethoxy benzothiazole (PK 26124), a proposed antagonist of excitatory amino acid neurotransmission, does not produce phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys'. Together they form a unique fingerprint.

Cite this